ProCE Banner Activity

Individualizing the Current Adjuvant Therapy Algorithm for Patients With HR+/HER2- EBC

Slideset

Download these slides covering the latest evidence and recommendations on how to individualize current adjuvant therapy for patients with HR+/HER2- EBC.

Released: December 06, 2024

Expiration: December 05, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation